We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Speedy Cell Cycle Slows Stem Cell Differentiation

By LabMedica International staff writers
Posted on 28 Dec 2017
A team of cell biologists has found that the ability of pluripotent stem cells to remain in an undifferentiated state is linked to the length of time the cell spends in the G1 phase of cell division.

All dividing cells must first unwind their DNA so that it can be copied. More...
To achieve this, cells load DNA-unwinding enzymes called helicases onto their DNA during the part of the cell cycle known as G1 phase. Cells must load enough helicase enzymes to ensure that their DNA is copied completely and in time. Stem cells divide faster than their specialized descendants, and have a much shorter G1 phase, as well. Yet these cells still manage to load enough helicases to copy their DNA. Little is known about how the amount, rate, and timing of helicase loading vary between cells that divide at different speeds.

Complete and robust human genome duplication requires loading minichromosome maintenance (MCM) helicase complexes at many DNA replication origins, an essential process termed origin licensing. Licensing is restricted to G1 phase of the cell cycle, but G1 length varies widely among cell types. Investigators at the University of North Carolina (Chapel Hill, USA) utilized single-cell flow cytometry to measure MCM loading rates in asynchronous populations of pluripotent and differentiated cells.

Results published in the November 17, 2017, online edition of the journal eLife revealed that pluripotent stem cells with naturally short G1 phases loaded MCM much faster than their isogenic differentiated counterparts with long G1 phases. During the earliest stages of differentiation toward all lineages, MCM loading slowed concurrently with G1 lengthening, revealing developmental control of MCM loading. Rapid licensing in stem cells was caused by accumulation of the MCM loading protein, Cdt1 (DNA replication factor Cdt1). Prematurely slowing MCM loading in pluripotent cells not only lengthened G1 but also accelerated differentiation. Thus, rapid origin licensing was an intrinsic characteristic of stem cells that contributed to pluripotency maintenance.

"Studies like this help explain the underlying biology of rapidly dividing cells and may inform the development of future therapies, for example stem cell therapies or cancer treatments," said study senior author Dr. Jean Cook, professor of biochemistry and biophysics at the University of North Carolina. "We suspect that rapid MCM loading is an important aspect of how cancer cells manage to grow fast without excessively damaging their DNA. It is a target worth pursuing."

Related Links:
University of North Carolina


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.